The PDX Model Market was valued at USD 177.32 million in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 13.8% from 2023 to 2029, reaching approximately USD 438.29 million by the end of the forecast period.
Market Overview
Patient-Derived Xenograft (PDX) models have garnered significant attention in recent years, driven by their potential to offer more...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian